Loading Events

Stability Studies for Homeopathic Products Part 1

AAHP Compliance Thru Education Special Two-Part Webinar


Monday, Dec. 4, 2017, and Monday, Dec. 11, 2017

Each day at 1 p.m. ET • 12 p.m. CT • 11 a.m. MT • 10 a.m. PT

How do stability studies and designs differ between homeopathic products and allopathic drugs?

What matters when conducting stability studies for homeopathic products?

Join us for this informative two-part webinar as Pejman Parhami and Aryo Nikopour outline essential information that places stability studies within a larger context of product quality, and not just a required task to establish expiration dating. Do you know how your product will behave in its packaging once it hits the market and sits on the shelves?

Products lacking adequate stability are not assets for your company; rather they represent liabilities. The most obvious use of stability information is to minimize customer complaints. At the same time, warehousing of products with inadequate stability information represents a hidden cost that could be better utilized by your company in increased sales and profits.

Participate in this webinar to gain insights into how stability findings can create products with competitive advantages. Concurrently, learn what the U.S. Food and Drug Administration increasingly expects from all homeopathic drug manufacturers and marketers.

This webinar will be presented in two sequential one-hour sessions a week apart to better accommodate your work schedule. Take advantage of this course to meet your required employee training needs.

Who Should Attend?

  • Company CEOs
  • Management responsible for compliance
  • Quality assurance managers
  • Quality assurance staff


Pejman Parhami obtained his bachelor’s degree in chemistry at age 20 from the University of Oklahoma, where he also took graduate studies in chemistry. Additionally, he holds an MBA in finance from Temple University. He is the senior director of quality systems for Hyland’s. He has more than 30 years of experience in R&D (at AstraZeneca and GlaxoSmithKline) and as head of Worldwide Quality (at Cephalon and MedImmune). His experience ranges from new product development and directing quality and validation operations for multinational pharmaceutical companies.

Aryo A. Nikopour obtained his bachelor’s degree in chemistry and mathematics from University of Southern Minnesota. He is SVP of Scientific & Technical Services at Nitto Avecia Pharma Services (formerly Irvine Pharmaceutical Services), where he was worked for the past 13 years. He has more than 29 years of experience in pharmaceutical and biopharmaceutical industries working for Solvay, Alpharma, and PPD. His experience ranges from new product development and directing analytical R&D, quality control, and stability groups. He has expertise in areas of method development and validation, stability studies, extractables/leachables and drug delivery (inhalation and nasal delivery systems).


Nonmembers: $299 for the two-part webinar series. AAHP members get a $120 discount with the promo code available from the office. The registration portal is being created as this newsletter is being distributed. A follow-up email will go to all subscribers of the AAHP NetworkNews with the active registration link. Mark your calendars now and set aside time to attend both one-hour sessions.


December 4, 2017
1:00 pm - 2:00 pm EST